{"id":"https://openalex.org/W4379280997","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e18758","title":"The impact of COVID-19 on patient involvement in treatment decisions in the US and EU4+UK.","display_name":"The impact of COVID-19 on patient involvement in treatment decisions in the US and EU4+UK.","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379280997","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e18758"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.e18758","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e18758","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e18758","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Elsa Ng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elsa Ng","raw_affiliation_strings":["Ipsos Insight, Kuala Lumpur, Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipsos Insight, Kuala Lumpur, Malaysia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046859911","display_name":"Angelena Moseley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092442","display_name":"Ipsos (United States)","ror":"https://ror.org/00g5g8212","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092442"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angelena Moseley","raw_affiliation_strings":["Ipsos Insight, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipsos Insight, New York, NY","institution_ids":["https://openalex.org/I4210092442"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070985106","display_name":"Federico Gallo","orcid":"https://orcid.org/0000-0003-0014-2538","observed_orcids":["https://orcid.org/0000-0003-0014-2538"]},"institutions":[{"id":"https://openalex.org/I4210092442","display_name":"Ipsos (United States)","ror":"https://ror.org/00g5g8212","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092442"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Federico Gallo","raw_affiliation_strings":["Ipsos Insight, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipsos Insight, New York, NY","institution_ids":["https://openalex.org/I4210092442"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"16_suppl","first_page":"e18758","last_page":"e18758"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10827","display_name":"Patient-Provider Communication in Healthcare","score":0.6333000063896179,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10827","display_name":"Patient-Provider Communication in Healthcare","score":0.6333000063896179,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts","score":0.3379000127315521,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10177","display_name":"Palliative Care and End-of-Life Issues","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9599999785423279},{"id":"https://openalex.org/keywords/patient-involvement","display_name":"patient involvement","score":0.8629999756813049},{"id":"https://openalex.org/keywords/shared-decision-making","display_name":"shared decision-making","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cancer-treatment-decisions","display_name":"cancer treatment decisions","score":0.9580000042915344},{"id":"https://openalex.org/keywords/oncologist-perspectives","display_name":"oncologists' perspectives","score":0.699999988079071},{"id":"https://openalex.org/keywords/physician-attitudes","display_name":"physician attitudes","score":0.6880000233650208},{"id":"https://openalex.org/keywords/patient-engagement","display_name":"patient engagement","score":0.3540000021457672},{"id":"https://openalex.org/keywords/physician-workload","display_name":"physician workload","score":0.42800000309944153},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.5910000205039978},{"id":"https://openalex.org/keywords/doctor-patient-communication","display_name":"physician-patient communication","score":0.4020000100135803},{"id":"https://openalex.org/keywords/patient-satisfaction-with-physician-patient-communication","display_name":"patient satisfaction with physician-patient communication","score":0.36800000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8149094581604004},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.7969846725463867},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.6624493598937988},{"id":"https://openalex.org/C2778476105","wikidata":"https://www.wikidata.org/wiki/Q628539","display_name":"Workload","level":2,"score":0.6183983683586121},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.6120046377182007},{"id":"https://openalex.org/C20387591","wikidata":"https://www.wikidata.org/wiki/Q930752","display_name":"Specialty","level":2,"score":0.5585118532180786},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.4635867774486542},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4434424936771393},{"id":"https://openalex.org/C65067816","wikidata":"https://www.wikidata.org/wiki/Q2295139","display_name":"Computer-assisted web interviewing","level":2,"score":0.4265378415584564},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.18342915177345276},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15135014057159424},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.16_suppl.e18758","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e18758","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e18758","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4220750659","https://openalex.org/W4379281193","https://openalex.org/W3080188819","https://openalex.org/W4281662951","https://openalex.org/W4399279750","https://openalex.org/W3089217886","https://openalex.org/W3178124820","https://openalex.org/W4391741684","https://openalex.org/W3092177693","https://openalex.org/W4388673906"],"abstract_inverted_index":{"e18758":[0],"Background:":[1],"The":[2,40,78,99,335],"COVID-19":[3,21,42,274],"pandemic":[4,142,419],"has":[5,330],"impacted":[6],"many":[7],"facets":[8],"of":[9,20,25,56,89,166,168,184,186,202,222,231,265,273,320,328,344,372,417,426],"the":[10,18,23,37,61,121,134,141,153,161,178,200,223,229,236,242,259,263,270,279,295,305,314,318,326,359,370,408,414,418,424],"healthcare":[11],"landscape.":[12],"This":[13,188,362],"study":[14,44,204,379],"aims":[15],"to":[16,50,128,140,190,208,211,249,301,354,365,386,396,403,436],"assess":[17],"effect":[19],"on":[22,105,420],"evolution":[24],"patient":[26,106,110,112,421,427],"involvement":[27,329,337,422],"in":[28,60,95,120,152,160,173,194,216,228,235,256,262,287,294,304,317,323,346,390,407],"cancer":[29,392],"treatment":[30,174,324,393,439],"decisions":[31,175,394],"at":[32,199,241,269,358,369],"different":[33,135],"time":[34,136,201,371],"points":[35,137],"throughout":[36],"pandemic.":[38],"Methods:":[39],"Ipsos":[41],"Evolution":[43],"was":[45,206,339],"run":[46],"online":[47],"from":[48,103,333,377],"April":[49],"June":[51],"2022":[52],"with":[53,92,138],"a":[54,72,76,239,290],"total":[55],"353":[57],"oncologists":[58],"responding":[59],"US":[62,162,195,347],"and":[63,75,87,116,118,151,192,196,205,213,245,252,283,298,310,341,348,352,356,367,399,423],"EU4+UK":[64,179,349],"(US:":[65],"100,":[66],"EU4+UK:":[67],"253).":[68],"Each":[69],"physician":[70],"completed":[71],"demographic":[73,79],"form":[74,80],"questionnaire.":[77],"gathered":[81],"information":[82,102,131],"regarding":[83],"specialty,":[84],"practice":[85],"type":[86],"volume":[88,264,319],"patients":[90,171,232,266,321,385,402],"treated":[91],"anti-cancer":[93],"drugs":[94],"an":[96,164,182,226],"average":[97,165,183,336],"month.":[98],"questionnaire":[100],"collected":[101],"physicians":[104,159,180,224,234,382],"workload,":[107],"diagnosis/tumor":[108],"characterization,":[109],"management,":[111],"treatment,":[113],"personal":[114],"attitude":[115],"events,":[117],"expectation":[119],"next":[122,154,306],"6":[123,155,217,307],"months.":[124,156,410],"Physicians":[125,255,286],"were":[126],"required":[127],"provide":[129,430,437],"this":[130,203,300,373,378],"by":[132],"referencing":[133],"regards":[139],"including":[143],"pre-pandemic,":[144,176],"1st":[145,243,271,360],"peak,":[146],"Delta/Omicron":[147,246,280],"spread,":[148],"current":[149,296],"state":[150,297],"Results:":[157],"Sampled":[158],"reported":[163,181,225,238,258,289,383],"50%":[167],"their":[169,384,391],"managed":[170],"involved":[172,268,322,389,406],"while":[177],"45%":[185],"patients.":[187],"increased":[189,332,364],"56%":[191],"53%":[193],"EU4+UK,":[197],"respectively,":[198,215],"expected":[207],"increase":[209,227,261],"further":[210,303,363,431],"57%":[212],"56%,":[214],"months\u2019":[218],"time.":[219],"While":[220],"most":[221],"proportion":[230],"involved,":[233],"UK":[237],"drop":[240],"peak":[244,272],"spread":[247,281],"compared":[248,395],"pre-pandemic":[250,351,397],"(-1%":[251],"-3%":[253],"respectively).":[254,285,312],"Germany":[257],"highest":[260],"being":[267],"that":[275],"quickly":[276],"dropped":[277],"during":[278],"(+18%":[282],"+6%,":[284],"Italy":[288],"much":[291],"bigger":[292],"change":[293],"predicted":[299,400],"grow":[302],"months":[308],"(+27%":[309],"+32%,":[311],"Besides":[313],"recorded":[315],"growth":[316],"decisions,":[325],"level":[327],"also":[331],"pre-pandemic.":[334],"score":[338],"4.8":[340],"4.7":[342],"out":[343],"7":[345],"respectively":[350],"grew":[353],"5.2":[355],"5.0":[357],"peak.":[361],"5.6":[366],"5.8":[368],"study.":[374],"Conclusions:":[375],"Results":[376],"highlighted":[380],"participating":[381],"be":[387],"more":[388,401],"levels":[398],"become":[404],"increasingly":[405],"coming":[409],"Further":[411,443],"investigation":[412,444],"into":[413,433],"continued":[415],"impact":[416],"benefits":[425],"participation":[428],"would":[429],"insight":[432],"optimal":[434],"ways":[435],"better":[438],"experiences":[440],"through":[441],"inclusivity.":[442],"using":[445],"comparator":[446],"cohort":[447],"is":[448],"warranted.":[449]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-06-05T00:00:00"}